Additionally, retinoic acid and the retinoic acid receptor-α agonist AM-580 was found to induce CD1d expression ex vivo in B-cell CLL cells from patients, promoting activation of cytotoxic invariant natural killer T (iNKT) cells [278]. This evidence concerns the gene CD1D and B-cell chronic lymphocytic leukemia.